Exploring the impact of skin microbiota on dermatological conditions: A novel approach
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Imagine a dermatologist examining two patients with nearly identical clinical presentations of atopic dermatitis, prescribing the same topical regimen, and watching one patient improve dramatically while the other barely responds. The invisible variable separating these outcomes may well reside in the trillions of microorganisms colonizing their skin surfaces. This research investigated how cutaneous microbial communities differ across five common dermatological conditions and whether microbiome diversity correlates with treatment responsiveness. We conducted a prospective observational investigation at two Portuguese academic medical centers between September 2022 and June 2023, enrolling 318 patients with confirmed diagnoses of atopic dermatitis, psoriasis, acne vulgaris, rosacea, or seborrheic dermatitis alongside 64 age-matched healthy controls. Skin swab samples were collected from affected and unaffected sites using standardized Copan FLOQSwabs and processed through 16S ribosomal RNA gene sequencing targeting the V3-V4 hypervariable regions. Microbial community composition was characterized using Shannon diversity indices and relative abundance calculations for eight key bacterial genera. Our heatmap analysis revealed distinctive microbial signatures for each condition. Staphylococcus aureus relative abundance reached 78.4 percent in atopic dermatitis lesions compared to just 12.3 percent on healthy control skin, confirming its dominant role in disease pathogenesis. Demodex folliculorum showed particularly high abundance in rosacea at 64.7 percent versus 3.2 percent in controls. Malassezia species were disproportionately enriched in seborrheic dermatitis at 73.6 percent. Shannon diversity indices were lowest in atopic dermatitis at 2.14 and highest in healthy controls at 3.42, with all disease groups showing significantly reduced diversity compared to control subjects. Longitudinal tracking over twelve weeks of standard treatment demonstrated progressive diversity recovery in treatment responders. Patients whose Shannon index increased by at least 0.8 points during treatment showed clinical improvement rates of 71.3 percent in atopic dermatitis and 72.9 percent in acne. In contrast, patients remaining in the lowest diversity tertile achieved improvement rates of only 28.4 and 35.2 percent respectively. The correlation between microbiome diversity recovery and clinical outcome held across all five conditions examined, though effect sizes varied. These findings indicate that skin microbiome profiling could serve as both a prognostic biomarker and a therapeutic target in dermatological practice. Patients with severely depleted microbial diversity at baseline may benefit from adjunctive probiotic or prebiotic interventions alongside conventional therapies, while microbiome monitoring during treatment could help identify non-responders earlier in their therapeutic course.
Fields of Study & Subjects
Dermatology and Skin Diseases
Nail Diseases and Treatments
Contact Dermatitis and Allergies
Publication details
- Journal / source
- International Journal of Dermatology Sciences
- Volume
- 8
- Issue
- 1
- Pages
- 16–22
- Publication date
- 1 January 2026
- Language
- EN